Important notice

Meds75+ – information regarding the use for persons aged 75+

Substances A-Z
  • Ta

  • Tacrolimusum
    Class B
    Lack of research evidence, clinical experience or efficacy among older persons.
  • Tadalafilum
    Used as "UROLOGICALS"
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even mild renal insufficiency. Reduce the dose in even mild hepatic insufficiency. Significant adverse reactions include hypotension, ortostatic hypotension, headache and visual disturbances. Take several interactions into account, especially with nitrates and alpha-blocking agents. Avoid consuming grapefruit during treatment.
  • Tafluprostum
    Class A
    Suitable for older persons. Start and continue therapy under supervision by an ophthalmologist. May cause alterations in iris pigmentation and growth of eyelashes.
  • Tamsulosini hydrochloridum
    Used as "UROLOGICALS"
    Class C
    Suitable for older persons, with specific cautions. Significant adverse effects include orthostatic hypotension, dizziness and risk for falls.
  • Te

  • Telmisartanum
    Class A
    Suitable for older persons. Monitor renal function during the pharmacotherapy. Avoid concurrent use of anti-inflammatory analgesics.
  • Terbinafini hydrochloridum
    Class C
    Suitable for older persons, with specific cautions. Reduce the dose in even moderate renal insufficiency. Contraindication: severe hepatic insufficiency. Take significant interactions into account.
    Class A
    Topical treatment: Suitable for older persons. Systemic absorption is low when applied on to the skin as specified in the instructions for use.
  • Terbinafinum
    Class A
    Topical treatment: Suitable for older persons. Systemic absorption is low when applied on to the skin as specified in the instructions for use.
  • Testosteroni decanoas
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Testosteroni isocaproas
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Testosteroni phenylpropionas
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Testosteroni propionas
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Testosteroni undecanoas
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Testosteronum
    Class D
    Avoid use in older persons. May be considered in cases of moderate or severe hypogonadism. Do not use on patients with prostate cancer. Note the risk of cardiovascular adverse reactions and possibility of psychiatric disorders.
  • Th

  • Thiamini hydrochloridum
    Used as "VITAMINS"
    Class A
    Suitable for older persons.
  • Thiamini nitras
    Used as "VITAMINS"
    Class A
    Suitable for older persons.
  • Ti

  • Ticagrelorum
    Class C
    Suitable for older persons, with specific cautions. A significant adverse effect is increased risk of bleeding. Take several interactions into account. Avoid consuming grapefruit juice during treatment.
  • Timololi maleas
    Class C
    Suitable for older persons, with specific cautions. Start and continue therapy under supervision by an ophthalmologist. Remember systemic adverse effects. Take interactions into account.
  • To

  • Tobramycinum
    Class A
    Suitable for older persons. For temporary use. Long term use only under supervision by an ophthalmologist. Do not use if fungal or viral infection is suspected.
  • Tr

  • Tramadoli hydrochloridum
    Used as "ANALGESICS"
    Class D
    Avoid use of tramadol and dexketoprofen in combination products in older persons. Opioid. Serotonergic. Prodrug. Genotype affects the response. Significant adverse effects include constipation, nausea, urinary difficulties, gallbladder problems and hyponatraemia. Increases risk of falling. Take interactions into account.
    Used as "ANALGESICS"
    Class D
    Avoid use in older persons. Opioid. Serotonergic. Prodrug. Genotype affects the response. Significant adverse effects include constipation, nausea, urinary difficulties, gallbladder problems and hyponatraemia. Increases risk of falling. Take interactions into account.
  • Travoprostum
    Class A
    Suitable for older persons. Start and continue therapy under supervision by an ophthalmologist. May cause alterations in iris pigmentation and growth of eyelashes.
  • Trazodoni hydrochloridum
    Class D
    Avoid use in older persons. Sedative. Serotonergic. Consider another antidepressant for primary treatment. Increases risk for falls. Take interactions into account. Avoid consuming grapefruit during treatment.
  • Tretinoinum
  • Triamcinoloni acetonidum
    Class A
    Topical treatment: Suitable for older persons.
    Class A
    Suitable for older persons.
  • Triazolamum
    Used as "PSYCHOLEPTICS"
    Class D
    Avoid use in older persons. Sedative. A short-acting. Significant adverse effects include drug addiction, rebound insomnia, amnesia, cognitive disorder and risk for traffic accidents. Increases risk for falls. Paradoxically, may increase anxiety, restlessness and aggression. Take several interactions into account. Avoid consuming grapefruit during treatment.
  • Trimethoprimum
    Class C
    Suitable for older persons. Reduce the dose in severe renal insufficiency. Contraindicated in case of severe hepatic insufficiency. Take into account the risks when used in combination with anti-inflammatory analgesics, AT1-blockers/ACE-inhibitors, spironolactone and clozapine.

Icon explanation

Class A A (green): Suitable for the older persons. The medicinal substance can be used as in younger patients. Changes due to aging do not affect the dose or frequency of administration, and the adverse reaction profile is not different from that of younger patients.

Class B B (grey): There is little research evidence, practical experience or efficacy in older persons.

Class C C (yellow): Suitable for older persons, with specific cautions. The medicinal substance can be used by older persons, but the dose might either have to be reduced, or the frequency of administration decreased due to mild or moderate renal insufficiency or a significant risk of interactions or adverse reactions.

Class D D (red): Avoid use in older persons. Use is possible only in exceptional cases or on a one-off basis. Changes due to aging predispose older persons to adverse or dangerous reactions to the drug. The risk of adverse reactions typically exceeds the benefits.

Meds75+ data source is Finnish Medicines Agency Fimea (licensed under CC BY 4.0).
Data updated on Mar 30, 2021.